The future of clinical experimentation in neonatal medicine

In an address to the British Neonatal Society, in 1993,1 Ola Saugstad spoke about the future of neonatal research; and he referred to Karl Popper's views concerning the limitations of inductive reasoning when trying to prove cause and effect in medicine. Saugstad's words remind me how hard...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 1994-12, Vol.94 (6), p.932-938
1. Verfasser:	SILVERMAN, W. A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Clinical trials Emergency and intensive care: neonates and children. Prematurity. Sudden death Forecasts and trends Human Experimentation Human experimentation in medicine Human medical experimentation Humans Infant, Newborn Intensive care medicine Medical research Medical sciences Neonatology Neonatology - methods Neonatology - trends Pediatrics Randomized Controlled Trials as Topic - methods Randomized Controlled Trials as Topic - trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In an address to the British Neonatal Society, in 1993,1 Ola Saugstad spoke about the future of neonatal research; and he referred to Karl Popper's views concerning the limitations of inductive reasoning when trying to prove cause and effect in medicine. Saugstad's words remind me how hard it has been to give up the conventional notion about the nature of scientific proof. Even at this late date many in our profession still believe that a statement is scientific, if it can be verified by objective observation, and that the truth of statements about natural events can be proven by repeated verifications.
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.94.6.932